Methylenedioxypyrovalerone (MDPV) is a synthetic, cathinone-derivative, central nervous system stimulant taken to produce a cocaine- or methamphetamine-like high. Physical manifestations include tachycardia, hypertension, arrhythmias, hyperthermia, sweating, rhabdomyolysis, hyperkalaemia, disseminated intravascular coagulation, oliguria and seizures. We report a patient who presented with severe metabolic acidosis, multi-organ dysfunction, rhabdomyolysis, hyperkalaemia and seizures. This case highlights that even though a urine drug screen for routine psychostimulant drugs is negative, clinicians need to be vigilant about the adverse effects of MDPV as a possible cause of multi-organ dysfunction. Substances such as this can only be detected by special tests, such as gas/liquid chromatography mass spectrometry. This is the first reported case of MDPV toxicity successfully treated in Australia to the best of our knowledge.

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13307DOI Listing

Publication Analysis

Top Keywords

multi-organ dysfunction
12
rhabdomyolysis hyperkalaemia
8
dysfunction bath
4
bath salts
4
salts aware
4
aware entity?
4
entity? methylenedioxypyrovalerone
4
methylenedioxypyrovalerone mdpv
4
mdpv synthetic
4
synthetic cathinone-derivative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!